Pharmacologic Treatments Effective in Both Generalized Anxiety Disorder and Major Depressive Disorder: Clinical and Theoretical Implications

Abstract

French

Objective:

To review the efficacy of anxiolytics (alprazolam and azapirones) in major depressive disorder (MDD) and that of antidepressants in generalized anxiety disorder (GAD), thereby exploring the possible theoretical and clinical implications of this efficacy.

Method:

A Medline literature search was performed for the period January 1980 to September 1997 of randomized, double-blind comparison studies between anxiolytics and antidepressants in the acute treatment of adult patients with either MDD or GAD.

Results:

Alprazolam, at doses double those generally recommended for anxiety disorders, appears to be as effective as tricyclic antidepressants (TCAs) in the acute treatment of mild to moderate MDD. Alprazolam was also found to have a more rapid onset of action than do TCAs, particularly for the improvement of anxiety, somatization, and insomnia. Two azapirones (buspirone andgepirone) also have demonstrated a modest acute antidepressant effect in preliminary studies, albeit only in a depressed outpatient sample with considerable anxiety at baseline. Finally, various antidepressant drugs (imipramine, trazodone, paroxetine) were shown to have, at the least, comparable efficacy to benzodiazepines (BZDs) in the acute treatment of GAD.

Conclusions:

The nonspecificity of treatment response suggests that GAD and MDD are 1) different expressions of a similar disorder with a common neurobiological substrate, 2) discrete diagnostic entities that respond to independent pharmacological effects of the same drugs, or 3) a combination of the two (heterogeneity hypothesis). The most relevant clinical finding is the efficacy of antidepressants in the acute treatment of GAD.

Keywords

depressive disorders anxiety disorders generalized anxiety disorder antidepressants antianxiety agents benzodiazepines buspirone

References

Andrews

Stewart

Morris-Yates

Holt

Henderson

. Evidence for a general neurotic syndrome. Br J Psychiatry 1990;157:6–12.

Klein

. Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 1964;5:397–408.

Klein

. Importance of psychiatric diagnosis in prediction of clinical drug effects. Arch Gen Psychiatry 1967;16:118–26.

Tyrer

Seivewright

Murphy

Ferguson

Kingdon

Barczak

, and others. The Nottingham study of neurotic disorder: Comparison of drug and psychological treatments. Lancet 1988;2:235–40.

Tyrer

Seivewright

Ferguson

Murphy

Johnson

. The Nottingham study of neurotic disorder: Effect of personality status on response to drug treatment, cognitive therapy, and self-help over two years. Br J Psychiatry 1993;162:219–26.

Andrews

Stewart

Allen

Henderson

. The genetics of six neurotic disorders: A twin study. J Affect Dis 1990;19:23–9.

Watson

Clark

. Negative affectivity: The disposition to experience negative emotional states. Psychol Bull 1984;96:465–90.

Clark

Watson

General affective dispositions and their importance in physical and psychological health. In: Handbook of social and clinical psychology: The health perspective. Snyder

Forsyth

, editors. New York: Pergamon Press; 1991. p 221–45.

Jardine

Martin

Henderson

. Genetic covariation between neuroticism and the symptoms of anxiety and depression. Genetic Epidemiol 1984;1:89–107.

10.

Kendler

Heath

Martin

Eaves

. Symptoms of anxiety and symptoms of depression: Same genes, different environments? Arch Gen Psychiatry 1987;44:451–7.

11.

Pedersen

Plomin

McClearn

Friberg

Neuroticism, extraversion, and related traits in adult twins reared apart and reared together. J Pers Soc Psychol 1988;55:950–7.

12.

Rose

. Genetic and environmental variance in content dimensions of the MMPI. J Pers Soc Psychol 1988;55:302–11.

13.

Tellegen

Lykken

Bouchard

Wilcox

Segal

Rich

Personality similarity in twins reared apart and together. J Pers Soc Psychol 1988;54:1031–9.

14.

Clark

Watson

Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. J Abnorm Psychol 1991;100:316–36.

15.

Clark

Watson

Mineka

Temperament, personality, and the mood and anxiety disorders. J Abnorm Psychol 1994;103:103–16.

16.

Kendler

Neale

Kessler

Heath

Eaves

. A longitudinal twin study of personality and major depression in women. Arch Gen Psychiatry 1993;50:853–62.

17.

Stahl

. Mixed anxiety and depression: Clinical implications. J Clin Psychiatry 1993;54(1 Suppl):33S–8S.

18.

Preskom

Fast

. Beyond signs and symptoms: The case against a mixed anxiety and depression category. J Clin Psychiatry 1993;54(1 Suppl):24S–32S.

19.

Joffe

Sokolov

Streiner

Antidepressant treatment of depression: A meta-analysis. Can J Psychiatry 1996;41:613–6.

20.

Anderson

Tomenson

. The efficacy of selective serotonin re-uptake inhibitors in depression: A meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994;8:238–42.

21.

Kasper

Fuger

Moller

. Comparative efficacy of antidepressants. Drugs 1992;43:11–23.

22.

Schatzberg

Cole

. Benzodiazepines in depressive disorders. Arch Gen Psychiatry 1978;35:1359–65.

23.

Petty

Trivedi

Fulton

Rush

. Benzodiazepines as antidepressants: Does GABA play a role in depression? Biol Psychiatry 1995;38:578–91.

24.

Jonas

Cohen

. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic and depression: A review of the literature. J Clin Psychiatry 1993;54(10 Suppl):25S–45S.

25.

Birkenhäger

Moleman

Nolen

. Benzodiazepines for depression? A review of the literature. Int Clin Psychopharmacolog 1995;10:181–95.

26.

Cole

Kando

. Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines. J Clin Psychiatry 1993;54(10 Suppl):49S–61S.

27.

Feighner

Aden

Fabre

Rickels

Smith

. Comparison of alprazolam, Imipramine and placebo in the treatment of depression. JAMA 1983;249:3057–64.

28.

Feighner

Meredith

Frost

Chammas

Hendrickson

A double-blind comparison of alprazolam vs imipramine and placebo in the treatment of major depressive disorder. Acta Psychiatr Scand 1983;68:223–33.

29.

Rickels

Feighner

Smith

. Alprazolam, amitriptyline, doxepin and placebo in the treatment of depression. Arch Gen Psychiatry 1985;42:134–41.

30.

Imlah

. An evaluation of alprazolam in treatment of reactive or neurotic (secondary) depression. Br J Psychiatry 1985;146:515–9.

31.

Mendels

Schless

. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients. J Clin Psychiatry 1986;47:357–61.

32.

Rickels

Chung

Csanalosi

Hurowitz

London

Wiseman

, and others. Alprazolam, diazepam, imipramine and placebo in outpatients with major depression. Arch Gen Psychiatry 1987;44:862–6.

33.

Fabre

McLendon

. A double-blind study comparing the efficacy and safety of alprazolam with imipramine and placebo in primary depression. Current Therapeutic Research 1980;27:474–82.

34.

Laakman

Faltermaier-Temizel

Bossert-Zaudig

Baghai

Lorkowski

Treatment of depressive outpatients with lorazepam, alprazolam, amitriptyline, and placebo. Psychopharmacology 1995;120:109–15.

35.

Borison

Sinha

Albrecht

Geber

Diamond

. Double-blind comparison of 3- and 6-mg fixed doses of alprazolam vs placebo in outpatients with major depressive disorder. Psychopharmacol Bull 1989;45(2):186–9.

36.

Rickels

Cohen

Csanalosi

Harris

Koepke

Werblowsky

Alprazolam and imipramine in depressed outpatients: A controlled study. Current Therapeutic Research 1982;42(6):157–64.

37.

Remick

Keller

Buchanan

Gison

Fleming

JAE

. A comparison of the efficacy and safety and alprazolam and desipramine in depressed outpatients. Can J Psychiatry 1988;33:590–4.

38.

Ansseau

Ansoms

Beckers

Bogaerts

Botte

De Buck

, and others. Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression. J Affect Dis 1984;7:287–96.

39.

Singh

Nair

NPV

Suranyi-Cadotte

Svhwartz

Lizondo

A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression. Can J Psychiatry 1988;33:218–22.

40.

Remick

Fleming

JAE

Buchanan

Keller

Hamilton

Loomer

, and others. A comparison of the safety and efficacy of alprazolam and desipramine in moderately severe depression. Can J Psychiatry 1985;30:597–601.

41.

Hubain

Castro

Mesters

de Martelaer

Mendlewicz

Alprazolam and amitriptyline in the treatment of major depressive disorder: A double-blind clinical and sleep EEG study. J Affect Disord 1990;18:67–73.

42.

Fawcett

Edwards

Kravitz

Jeffries

Alprazolam: An antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. J Clin Psychopharmacol 1987;7:295–310.

43.

Overall

Biggs

Jacobs

Holden

Comparison of alprazolam and imipramine for the treatment of outpatient depression. J Clin Psychiatry 1987;48:15–9.

44.

Goldberg

Ettigi

Schulz

Hamer

Hayes

Friedel

. Alprazolam vs imipramine in depressed outpatients with neurovegetative signs. J Affect Disord 1986;11:139–45.

45.

Eriksson

Nagy

Sarmark

Thelander

Alprazolam compared to amitriptyline in the treatment of major depression. Acta Psychiatr Scand 1987;75:656–63.

46.

Rush

Erman

Schlesser

Roffwarg

Vasavada

Khatami

, and others. Alprazolam vs amitriptyline in depressions with reduced REM lacticies. Arch Gen Psychiatry 1985;42:1154–9.

47.

Lapierre

Browne

Oyewumi

Sarantidis

Alprazolam and amitriptyline in the treatment of moderate depression. Int Clin Psychopharmacol 1994;9:41–5.

48.

Gibbons

Clark

Kupfer

. Exactly what does the Hamilton Depression Rating Scale measure? J Psychiatr Res 1993;27(3):259–73.

49.

Maier

Philipp

Gerken

Dimensions of the Hamilton Depression Scale. European Archives of Psychiatry and Neurological Sciences 1985;234:417–22.

50.

Rehm

O'Hara

. Item characteristics of the Hamilton Rating Scale for Depression. J Psychiatr Res 1985;19:31–41.

51.

Cutler

Sramek

Hesselink

Keppel JM

Krol

Roeschen

Rickels

, and others. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: A prospective multicenter trial. J Clin Psychopharmacol 1993;13:429–37.

52.

Deakin

JFW

. A review of clinical efficacy of 5-HT1A agonists in anxiety and depression. J Psychopharmacol 1993;7(3):283–9.

53.

Sussman

The uses of buspirone in psychiatry. J Clin Psychiatry Monograph 1994;12:3–19.

54.

Eison

. The new generation of serotonergic anxiolytics: Possible clinical roles Psychopathology 1989;22(1 Suppl):13S–20S.

55.

Fabre

. Buspirone in the management of major depression: A placebo- controlled comparison. J Clin Psychiatry 1990;51(9 Suppl):55S–61S.

56.

Rickels

Amsterdam

Clary

Puzzuoli

Schweizer

Buspirone in major depression: A controlled study. J Clin Psychiatry 1991;52:34–8.

57.

Robinson

Rickels

Feighner

Fabre

Gammans

Shrotriya

, and others. Clincal effects of the 5-HT1A partial agonists in depression: A composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol 1990;10(3 Suppl):67S–76S.

58.

Heller

Beneke

Kuemmel

Spencer

Kurtz

. Ipsapirone: Evidence for efficacy in depression. Psychopharmacol Bull 1990;26:219–22.

59.

Jenkins

Robinson

Fabre

Andary

Messina

Reich

. Gepirone in the treatment of major depression. J Clin Psychopharmacol 1990;10(3 Suppl):77S–85S.

60.

Brawman-Mintzer

Lydiard

. Generalized anxiety disorder: Issues in epidemiology. J Clin Psychiatry 1996;57(7 Suppl):3S–8S.

61.

Schweizer

Rickels

The long-term management of generalized anxiety disorder: Issues and dilemmas. J Clin Psychiatry 1996;57(7 Suppl):9S–12S.

62.

Massion

Warshaw

Keller

. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry 1993;150:600–607.

63.

Roy-Byrne

. Generalized anxiety and mixed anxiety-depression: Association with disability and health care utilization. J Clin Psychiatry 1996;57(7 Suppl):86S–91S.

64.

Rickels

Case

Downing

Winokur

Long-term diazepam therapy and clinical outcome. JAMA 1983;250:767–71.

65.

Shader

Greenblatt

. Use of benzodiazepines in anxiety disorders. N Engl J Med 1993;328:1398–405.

66.

Rickels

Buspirone in clinical practice. J Clin Psychiatry 1990;51(9 Suppl):51S–4S.

67.

Liebowitz

Fyer

Gorman

Campeas

Sandberg

Hollander

, and others. Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research. J Psychiatr Res 1988;22(1 Suppl):7S–31S.

68.

Kahn

McNair

Lipman

Covi

Rickels

Downing

, and others. Imipramine and chlordiazepoxide in depressive and anxiety disorders II. Efficacy in anxious outpatients. Arch Gen Psychiatry 1986;43:79–85.

69.

Klein

. False suffocation alarms, spontaneous panics, and related conditions: An integrative hypothesis. Arch Gen Psychiatry 1993;50:306–17.

70.

Klein

. Panic disorder and agoraphobia: Hypothesis hothouse. J Clin Psychiatry 1996;57(6 Suppl):21S–27S.

71.

Hoehn-Saric

McLeod

Zimmerli

. Differential effects of alprazolam and imipramine in generalized anxiety disorder: Somatic versus psychic symptoms. J Clin Psychiatry 1988;49:293–301.

72.

Rickels

Downing

Schweizer

Hassman

Antidepressants for the treatment of generalized anxiety disorder: A placebo-controlled comparison of imipramine, trazodone and diazepam. Arch Gen Psychiatry 1993;50:884–95.

73.

Rocca

Fonzo

Scotta

Zanalda

Ravizza

Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997;95:444–50.

74.

Liebowitz

Hollander

Schneier

Anxiety and depression: Discrete diagnostic entities?

J Clin Psychopharmacol 1990;10(3 Suppl):61S–66S.

75.

Hollander

Cohen

. The assessment and treatment of refractory anxiety. J Clin Psychiatry 1994;55(2 Suppl):27S–31S.

76.

Garvey

Cook

Noyes

The occurrence of a prodrome of generalized anxiety in panic disorder. Compr Psychiatry 1988;29:445–9.

77.

Nisita

Petracca

Akiskal

Galli

Gepponi

Cassano

. Delimitation of generalized anxiety disorder: Clinical comparisons with panic and major depressive disorders. Compr Psychiatry 1990;31:409–15.

78.

Brown

Barlow

Leibowitz

. The empirical basis of generalized anxiety disorder. Am J Psychiatry 1994;151:1272–80.

79.

Kendler

Neale

Kessler

Heath

Eaves

. Major depression and generalized anxiety disorder: Same genes, (partly) different environments? Arch Gen Psychiatry 1992;49:716–22.

80.

Roy

Neale

Pedersen

Mathé

Kendler

. A twin study of generalized anxiety disorder and major depression. Psychol Med 1995;25:1037–49.

81.

Reich

Family psychiatric histories in male patients with generalized anxiety disorder and major depressive disorder. Ann Clin Psychiatry 1995;7:71–8.

82.

Kendler

. Major depression and generalized anxiety disorder: Same genes, (partly) different environments – revisited. Br J Psychiatry 1996; 168(30 Suppl):68S–75S.

83.

Kendler

Walters

Neale

Kessler

Heath

Eaves

. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Arch Gen Psychiatry 1995;52:374–83.

84.

Tiller

JWG

Biddle

Maguire

Davies

. The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biol Psychiatry 1988;23:261–70.

85.

Butler

Nemeroff

. Corticotropin-releasing factor as a possible cause of comorbidity in anxiety and depressive disorders. In: Maser

Cloninger

, editors. Comorbidity of mood and anxiety disorders. Washington (DC): American Psychiatric Press; 1990. pp 413–35.

86.

Abelson

Glitz

Cameron

Lee

Bronzo

Curtis

. Blunted growth hormone response to clomdine in patients with generalized anxiety disorder. Arch Gen Psychiatry 1991;48:157–62.

87.

Copp

Schwiderski

Robinson

. Symptom comorbidity in anxiety and depressive disorders. J Clin Psychopharmacol 1990;10(3 Suppl):52S–60S.

88.

Riskind

Beck

Brown

Steer

. Validity of reconstructed Hamilton Scales. J Nerv Ment Dis 1987;175:474–9.

89.

Wittchen

Zhao

Kessler

Eaves

. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:355–64.

90.

Clark

Steer

Beck

. Common and specific dimensions of self-reported anxiety and depression: Implications for the cognitive and tripartite models. J Abnorm Psychol 1994;103:645–54.

91.

Clark

Beck

. Symptom differences in major depression, dysthymia, panic disorder, and generalized anxiety disorder. Am J Psychiatry 1994;151:205–9.

92.

Boulenger

Lavallée

. Mixed anxiety and depression: Diagnostic issues. J Clin Psychiatry 1993;54(1 Suppl):3S–8S.

93.

Eison

. Serotonin: A common neurobiologic substrate in anxiety and depression. J Clin Psychopharmacol 1990;10(3 Suppl):26S–30S.